Merck & Co., Inc. Employee Service Share-based Compensation, Unrecognized Compensation Costs on Nonvested Awards, Weighted Average Period of Recognition (Deprecated 2011-01-31)
Merck & Co., Inc. (MRK) reported Employee Service Share-based Compensation, Unrecognized Compensation Costs on Nonvested Awards, Weighted Average Period of Recognition (Deprecated 2011-01-31) of 230.00% for the 3-month period ending 2011-03-31, per its 10-Q filed 2011-05-09.
Discontinued › Notes › Compensation Related Costs
us-gaap:EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsOnNonvestedAwardsWeightedAveragePeriodOfRecognition · last filed 2011-05-09
- Merck & Co., Inc. employee service share-based compensation, unrecognized compensation costs on nonvested awards, weighted average period of recognition (deprecated 2011-01-31) for the quarter ending 2011-03-31 was 230.00%.
- Merck & Co., Inc. employee service share-based compensation, unrecognized compensation costs on nonvested awards, weighted average period of recognition (deprecated 2011-01-31) for fiscal 2010 was 180.00%.
| Period end | Employee Service Share-based Compensation, Unrecognized Compensation Costs on Nonvested Awards, Weighted Average Period of Recognition (Deprecated 2011-01-31) 3 month | Employee Service Share-based Compensation, Unrecognized Compensation Costs on Nonvested Awards, Weighted Average Period of Recognition (Deprecated 2011-01-31) 6 month | Employee Service Share-based Compensation, Unrecognized Compensation Costs on Nonvested Awards, Weighted Average Period of Recognition (Deprecated 2011-01-31) 9 month | Employee Service Share-based Compensation, Unrecognized Compensation Costs on Nonvested Awards, Weighted Average Period of Recognition (Deprecated 2011-01-31) 12 month |
|---|---|---|---|---|
| 2011-03-31 | 230.00% 10-Q · filed 2011-05-09 | |||
| 2010-12-31 | 180.00% 10-K · filed 2011-02-28 | |||
| 2010-09-30 | 190.00% 10-Q · filed 2010-11-08 | |||
| 2010-06-30 | 190.00% 10-Q · filed 2010-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |